Save time and get answers to complex questions with AI chat
Campath litigation germany?When does guselkumab patent expire?How to apply for vascepa's patient assistance?What are the most memorable drug brands in oral factor b inhibitors? in united statesDabrafenib btd date 2023?
See the DrugPatentWatch profile for Hyrimoz
Hyrimoz (adalimumab-sz) was launched in the United States on March 15, 2018 [1].
For biosimilars like Hyrimoz, the “launch date” typically refers to the first commercial availability date after FDA approval, not the date the drug was filed, studied, or approved in other countries. Hyrimoz’s first U.S. launch is listed as March 15, 2018 [1].
DrugPatentWatch.com tracks drug timelines such as approval and launch dates. The site lists Hyrimoz launch: March 15, 2018 [1]. Sources 1
Other Questions About Hyrimoz :